|
|
|
|
|
Legal status
Patent revoked (after opposition at EPO)
| (51) | INT.CL. | A61K 38/02 | (2006.01) |
| A61K 38/16 | (2006.01) | ||
| A61P 25/28 | (2006.01) | ||
| A61K 38/07 | (2006.01) | ||
| A61K 9/00 | (2006.01) | ||
| A61K 31/785 | (2006.01) | ||
| A61K 31/19 | (2006.01) |
| (11) | Number of the document | 3199172 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17157735.6 |
| Date of filing the European patent application | 2010-08-19 | |
| (97) | Date of publication of the European application | 2017-08-02 |
| (45) | Date of publication and mention of the grant of the patent | 2018-07-11 |
| (46) | Date of publication of the claims translation | 2018-10-25 |
| (30) | Number | Date | Country code |
| 274687 P | 2009-08-20 | US | |
| 337612 P | 2010-02-11 | US |
| (72) |
KLINGER, Ety, IL
|
| (73) |
Yeda Research and Development Co., Ltd.,
P.O.Box 95,, 76100 Rehovot,
IL
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Dozavimo režimas, skirtas išsėtinei sklerozei |
| DOSING REGIMEN FOR MULTIPLE SCLEROSIS |
| Payment date | Validity (years) | Amount | |
| 2023-07-20 | 14 | 289.00 EUR |
| Patent revoked (after opposition at EPO) | ||
| Invalidation date | 2024-02-07 |